Core Viewpoint - The collaboration between Meinian Health, Guofu Quantum, and Jingbeifang aims to explore the value release of digital assets in the healthcare sector, leveraging each company's strengths to innovate and upgrade the health industry [1][4]. Group 1: Collaboration and Strategic Goals - Meinian Health's subsidiary has signed a framework agreement with Guofu Quantum and Jingbeifang to explore comprehensive business opportunities in the digital asset RWA (Real World Asset) field [1]. - The partnership will focus on the tokenization of medical assets under the regulatory frameworks of mainland China and Hong Kong, aiming to reshape the value chain in the healthcare sector [1][4]. - This collaboration is expected to transform Meinian Health from a "health examination service provider" to a "medical data technology platform," enhancing its cash flow structure and expanding its business capabilities [4]. Group 2: Asset and Data Strengths - As of 2024, Meinian Health operates 576 health examination centers equipped with advanced medical devices, establishing a solid foundation of tangible assets [2]. - The company has served over 200 million people, with more than 25 million health examinations conducted in 2024, accumulating extensive multimodal health data [2][9]. - Meinian Health has developed AI applications for health management, including intelligent health managers and disease risk prediction models, which enhance its service offerings and operational efficiency [2][8]. Group 3: Research and Development Achievements - Meinian Health has led a national key research project to build a health examination big data cloud platform, gathering over 130 million health examination records, which supports the value of its data assets [6][7]. - The company has published numerous research papers based on its health examination data, contributing to significant findings in public health and disease prevention [17][18]. - Collaborations with prestigious medical institutions have resulted in breakthroughs in various health-related research projects, further validating the commercial potential of its data [16][18]. Group 4: Unique Data Advantages - Meinian Health's health examination data focuses on asymptomatic populations, providing unique insights for early disease detection and prevention [11]. - The data's medical-grade accuracy and comprehensive multimodal integration enhance its value for serious medical research compared to consumer-grade health monitoring devices [12][13]. - The company's annual health examinations create a natural cohort tracking mechanism, ensuring high compliance and data integrity for longitudinal studies [14][15].